334 related articles for article (PubMed ID: 37366821)
1. Gut-on-a-Chip Research for Drug Development: Implications of Chip Design on Preclinical Oral Bioavailability or Intestinal Disease Studies.
Donkers JM; van der Vaart JI; van de Steeg E
Biomimetics (Basel); 2023 May; 8(2):. PubMed ID: 37366821
[TBL] [Abstract][Full Text] [Related]
2. Microfluidic Gut-on-a-Chip: Fundamentals and Challenges.
Thomas DP; Zhang J; Nguyen NT; Ta HT
Biosensors (Basel); 2023 Jan; 13(1):. PubMed ID: 36671971
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic and pharmacodynamic insights from microfluidic intestine-on-a-chip models.
Lee SH; Choi N; Sung JH
Expert Opin Drug Metab Toxicol; 2019 Dec; 15(12):1005-1019. PubMed ID: 31794278
[No Abstract] [Full Text] [Related]
4. The Progress of Intestinal Epithelial Models from Cell Lines to Gut-On-Chip.
Rahman S; Ghiboub M; Donkers JM; van de Steeg E; van Tol EAF; Hakvoort TBM; de Jonge WJ
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948271
[TBL] [Abstract][Full Text] [Related]
5. Gut-on-a-chip: Mimicking and monitoring the human intestine.
Marrero D; Pujol-Vila F; Vera D; Gabriel G; Illa X; Elizalde-Torrent A; Alvarez M; Villa R
Biosens Bioelectron; 2021 Jun; 181():113156. PubMed ID: 33761417
[TBL] [Abstract][Full Text] [Related]
6. Dynamic in vitro intestinal barrier model coupled to chip-based liquid chromatography mass spectrometry for oral bioavailability studies.
Santbergen MJC; van der Zande M; Gerssen A; Bouwmeester H; Nielen MWF
Anal Bioanal Chem; 2020 Feb; 412(5):1111-1122. PubMed ID: 31865418
[TBL] [Abstract][Full Text] [Related]
7. Gut-on-a-chip for disease models.
Xian C; Zhang J; Zhao S; Li XG
J Tissue Eng; 2023; 14():20417314221149882. PubMed ID: 36699635
[TBL] [Abstract][Full Text] [Related]
8. An Organ-on-Chip Platform for Simulating Drug Metabolism Along the Gut-Liver Axis.
Lucchetti M; Aina KO; Grandmougin L; Jäger C; Pérez Escriva P; Letellier E; Mosig AS; Wilmes P
Adv Healthc Mater; 2024 Mar; ():e2303943. PubMed ID: 38452399
[TBL] [Abstract][Full Text] [Related]
9. Gut-on-chip: Recreating human intestine in vitro.
Xiang Y; Wen H; Yu Y; Li M; Fu X; Huang S
J Tissue Eng; 2020; 11():2041731420965318. PubMed ID: 33282173
[TBL] [Abstract][Full Text] [Related]
10. Recent Advances in Gut- and Gut-Organ-Axis-on-a-Chip Models.
Kim R; Sung JH
Adv Healthc Mater; 2024 Jan; ():e2302777. PubMed ID: 38243887
[TBL] [Abstract][Full Text] [Related]
11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
12. The translational roadmap of the gut models, focusing on gut-on-chip.
Malaguarnera G; Graute M; Homs Corbera A
Open Res Eur; 2021; 1():62. PubMed ID: 37645178
[TBL] [Abstract][Full Text] [Related]
13. Harnessing the Biology of Canine Intestinal Organoids to Heighten Understanding of Inflammatory Bowel Disease Pathogenesis and Accelerate Drug Discovery: A One Health Approach.
Kopper JJ; Iennarella-Servantez C; Jergens AE; Sahoo DK; Guillot E; Bourgois-Mochel A; Martinez MN; Allenspach K; Mochel JP
Front Toxicol; 2021; 3():773953. PubMed ID: 35295115
[TBL] [Abstract][Full Text] [Related]
14. In vitro prediction of gastrointestinal absorption and bioavailability: an experts' meeting report.
Pelkonen O; Boobis AR; Gundert-Remy U;
Eur J Clin Pharmacol; 2001 Nov; 57(9):621-9. PubMed ID: 11791890
[TBL] [Abstract][Full Text] [Related]
15. A Biomimetic Human Gut-on-a-Chip for Modeling Drug Metabolism in Intestine.
Guo Y; Li Z; Su W; Wang L; Zhu Y; Qin J
Artif Organs; 2018 Dec; 42(12):1196-1205. PubMed ID: 30256442
[TBL] [Abstract][Full Text] [Related]
16. A higher throughput and physiologically relevant two-compartmental human ex vivo intestinal tissue system for studying gastrointestinal processes.
Stevens LJ; van Lipzig MMH; Erpelinck SLA; Pronk A; van Gorp J; Wortelboer HM; van de Steeg E
Eur J Pharm Sci; 2019 Sep; 137():104989. PubMed ID: 31301485
[TBL] [Abstract][Full Text] [Related]
17. Head-to-Head Comparison of Caco-2 Transwell and Gut-on-a-Chip Models for Assessing Oral Peptide Formulations.
Gleeson JP; Zhang SY; Subelzu N; Ling J; Nissley B; Ong W; Nofsinger R; Kesisoglou F
Mol Pharm; 2024 Jun; ():. PubMed ID: 38941485
[TBL] [Abstract][Full Text] [Related]
18. Could the gut microbiota reconcile the oral bioavailability conundrum of traditional herbs?
Chen F; Wen Q; Jiang J; Li HL; Tan YF; Li YH; Zeng NK
J Ethnopharmacol; 2016 Feb; 179():253-64. PubMed ID: 26723469
[TBL] [Abstract][Full Text] [Related]
19. Advances of microfluidic intestine-on-a-chip for analyzing anti-inflammation of food.
Liang D; Su W; Tan M
Crit Rev Food Sci Nutr; 2022; 62(16):4418-4434. PubMed ID: 33480263
[TBL] [Abstract][Full Text] [Related]
20. Modulation of oral bioavailability of anticancer drugs: from mouse to man.
Schellens JH; Malingré MM; Kruijtzer CM; Bardelmeijer HA; van Tellingen O; Schinkel AH; Beijnen JH
Eur J Pharm Sci; 2000 Dec; 12(2):103-10. PubMed ID: 11102737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
